Covid-19 Impact on Global Acute Agitation and Aggression Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Agitation and Aggression Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Acute Agitation and Aggression Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Intramuscular Injection
1.4.4 Others
1.5 Market by Application
1.5.1 Global Acute Agitation and Aggression Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Ambulatory Surgical Centers
1.5.3 Psychiatric Care Facilities
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Acute Agitation and Aggression Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Acute Agitation and Aggression Treatment Industry
1.6.1.1 Acute Agitation and Aggression Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Acute Agitation and Aggression Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Acute Agitation and Aggression Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Acute Agitation and Aggression Treatment Market Perspective (2015-2026)
2.2 Acute Agitation and Aggression Treatment Growth Trends by Regions
2.2.1 Acute Agitation and Aggression Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acute Agitation and Aggression Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Acute Agitation and Aggression Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Acute Agitation and Aggression Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Acute Agitation and Aggression Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acute Agitation and Aggression Treatment Players by Market Size
3.1.1 Global Top Acute Agitation and Aggression Treatment Players by Revenue (2015-2020)
3.1.2 Global Acute Agitation and Aggression Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Acute Agitation and Aggression Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Agitation and Aggression Treatment Market Concentration Ratio
3.2.1 Global Acute Agitation and Aggression Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acute Agitation and Aggression Treatment Revenue in 2019
3.3 Acute Agitation and Aggression Treatment Key Players Head office and Area Served
3.4 Key Players Acute Agitation and Aggression Treatment Product Solution and Service
3.5 Date of Enter into Acute Agitation and Aggression Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Acute Agitation and Aggression Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acute Agitation and Aggression Treatment Forecasted Market Size by Type (2021-2026)
5 Acute Agitation and Aggression Treatment Breakdown Data by Application (2015-2026)
5.1 Global Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
5.2 Global Acute Agitation and Aggression Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acute Agitation and Aggression Treatment Market Size (2015-2020)
6.2 Acute Agitation and Aggression Treatment Key Players in North America (2019-2020)
6.3 North America Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
6.4 North America Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acute Agitation and Aggression Treatment Market Size (2015-2020)
7.2 Acute Agitation and Aggression Treatment Key Players in Europe (2019-2020)
7.3 Europe Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
7.4 Europe Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
8 China
8.1 China Acute Agitation and Aggression Treatment Market Size (2015-2020)
8.2 Acute Agitation and Aggression Treatment Key Players in China (2019-2020)
8.3 China Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
8.4 China Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acute Agitation and Aggression Treatment Market Size (2015-2020)
9.2 Acute Agitation and Aggression Treatment Key Players in Japan (2019-2020)
9.3 Japan Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
9.4 Japan Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acute Agitation and Aggression Treatment Market Size (2015-2020)
10.2 Acute Agitation and Aggression Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
11 India
11.1 India Acute Agitation and Aggression Treatment Market Size (2015-2020)
11.2 Acute Agitation and Aggression Treatment Key Players in India (2019-2020)
11.3 India Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
11.4 India Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acute Agitation and Aggression Treatment Market Size (2015-2020)
12.2 Acute Agitation and Aggression Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Agitation and Aggression Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acute Agitation and Aggression Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Details
13.1.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.1.3 Eli Lilly and Company Acute Agitation and Aggression Treatment Introduction
13.1.4 Eli Lilly and Company Revenue in Acute Agitation and Aggression Treatment Business (2015-2020))
13.1.5 Eli Lilly and Company Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Acute Agitation and Aggression Treatment Introduction
13.2.4 Pfizer Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Ono Pharmaceutical
13.3.1 Ono Pharmaceutical Company Details
13.3.2 Ono Pharmaceutical Business Overview and Its Total Revenue
13.3.3 Ono Pharmaceutical Acute Agitation and Aggression Treatment Introduction
13.3.4 Ono Pharmaceutical Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.3.5 Ono Pharmaceutical Recent Development
13.4 Otsuka Holdings
13.4.1 Otsuka Holdings Company Details
13.4.2 Otsuka Holdings Business Overview and Its Total Revenue
13.4.3 Otsuka Holdings Acute Agitation and Aggression Treatment Introduction
13.4.4 Otsuka Holdings Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.4.5 Otsuka Holdings Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Acute Agitation and Aggression Treatment Introduction
13.5.4 GlaxoSmithKline Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Treatment Introduction
13.6.4 Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview and Its Total Revenue
13.7.3 Johnson & Johnson Acute Agitation and Aggression Treatment Introduction
13.7.4 Johnson & Johnson Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 H. Lundbeck A/S
13.8.1 H. Lundbeck A/S Company Details
13.8.2 H. Lundbeck A/S Business Overview and Its Total Revenue
13.8.3 H. Lundbeck A/S Acute Agitation and Aggression Treatment Introduction
13.8.4 H. Lundbeck A/S Revenue in Acute Agitation and Aggression Treatment Business (2015-2020)
13.8.5 H. Lundbeck A/S Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Acute Agitation and Aggression Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Agitation and Aggression Treatment Revenue
Table 3. Ranking of Global Top Acute Agitation and Aggression Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Agitation and Aggression Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Intramuscular Injection
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Acute Agitation and Aggression Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Acute Agitation and Aggression Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Acute Agitation and Aggression Treatment Players to Combat Covid-19 Impact
Table 13. Global Acute Agitation and Aggression Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Acute Agitation and Aggression Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Acute Agitation and Aggression Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Acute Agitation and Aggression Treatment Market Share by Regions (2015-2020)
Table 17. Global Acute Agitation and Aggression Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Acute Agitation and Aggression Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Acute Agitation and Aggression Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Acute Agitation and Aggression Treatment Players
Table 24. Global Acute Agitation and Aggression Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Acute Agitation and Aggression Treatment Market Share by Players (2015-2020)
Table 26. Global Top Acute Agitation and Aggression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Agitation and Aggression Treatment as of 2019)
Table 27. Global Acute Agitation and Aggression Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Acute Agitation and Aggression Treatment Product Solution and Service
Table 30. Date of Enter into Acute Agitation and Aggression Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Acute Agitation and Aggression Treatment Market Size Share by Type (2015-2020)
Table 34. Global Acute Agitation and Aggression Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Acute Agitation and Aggression Treatment Market Size Share by Application (2015-2020)
Table 36. Global Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Acute Agitation and Aggression Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 40. North America Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 42. North America Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 46. Europe Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 48. Europe Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 52. China Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 54. China Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 58. Japan Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 60. Japan Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 64. Southeast Asia Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 70. India Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 72. India Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Acute Agitation and Aggression Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Acute Agitation and Aggression Treatment Market Share (2019-2020)
Table 76. Central & South America Acute Agitation and Aggression Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Acute Agitation and Aggression Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Acute Agitation and Aggression Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Acute Agitation and Aggression Treatment Market Share by Application (2015-2020)
Table 80. Eli Lilly and Company Company Details
Table 81. Eli Lilly and Company Business Overview
Table 82. Eli Lilly and Company Product
Table 83. Eli Lilly and Company Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 84. Eli Lilly and Company Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Ono Pharmaceutical Company Details
Table 91. Ono Pharmaceutical Business Overview
Table 92. Ono Pharmaceutical Product
Table 93. Ono Pharmaceutical Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 94. Ono Pharmaceutical Recent Development
Table 95. Otsuka Holdings Company Details
Table 96. Otsuka Holdings Business Overview
Table 97. Otsuka Holdings Product
Table 98. Otsuka Holdings Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 99. Otsuka Holdings Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Product
Table 103. GlaxoSmithKline Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 104. GlaxoSmithKline Recent Development
Table 105. Bristol-Myers Squibb Company Details
Table 106. Bristol-Myers Squibb Business Overview
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Johnson & Johnson Company Details
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Product
Table 113. Johnson & Johnson Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 114. Johnson & Johnson Recent Development
Table 115. H. Lundbeck A/S Business Overview
Table 116. H. Lundbeck A/S Product
Table 117. H. Lundbeck A/S Company Details
Table 118. H. Lundbeck A/S Revenue in Acute Agitation and Aggression Treatment Business (2015-2020) (Million US$)
Table 119. H. Lundbeck A/S Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Acute Agitation and Aggression Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Intramuscular Injection Features
Figure 4. Others Features
Figure 5. Global Acute Agitation and Aggression Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Ambulatory Surgical Centers Case Studies
Figure 7. Psychiatric Care Facilities Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Agitation and Aggression Treatment Report Years Considered
Figure 10. Global Acute Agitation and Aggression Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Acute Agitation and Aggression Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Acute Agitation and Aggression Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Acute Agitation and Aggression Treatment Market Share by Players in 2019
Figure 15. Global Top Acute Agitation and Aggression Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Agitation and Aggression Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Acute Agitation and Aggression Treatment Revenue in 2019
Figure 17. North America Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Acute Agitation and Aggression Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Eli Lilly and Company Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 28. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Ono Pharmaceutical Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 30. Otsuka Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Otsuka Holdings Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 34. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bristol-Myers Squibb Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 36. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Johnson & Johnson Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 38. H. Lundbeck A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. H. Lundbeck A/S Revenue Growth Rate in Acute Agitation and Aggression Treatment Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed